Antibody-mediated Early Death in vivo after Infection with Yellow Fever Virus

References

1. Brandt W. E., McCown J. M., Gentry M. K., Russell P. K. 1982; Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infection and Immunity 36:1036–1041
   [Google Scholar]
2. Buckley A., Gould E. A. 1985; Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. Journal of General Virology 66:2523–2531
   [Google Scholar]
3. Cammack N., Gould E. A. 1986a; Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus. Virology 150:333–341
   [Google Scholar]
4. Cammack N., Gould E. A. 1986b; Antigenic analysis of yellow fever virus glycoproteins: use of monoclonal antibodies in enzyme-linked immunosorbent assays. Journal of Virological Methods 13:135–142
   [Google Scholar]
5. Gould E. A., Buckley A., Cammack N., Barrett A. D. T., Clegg J. C. S., Ishak R., Varma M. G. R. 1985; Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. Journal of General Virology 66:1369–1382
   [Google Scholar]
6. Gould E. A., Buckley A., Barrett A. D. T., Cammack N. 1986; Neutralizing (54K) and non-neutralizing (54K. and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
   [Google Scholar]
7. Halstead S. B. 1979; In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. Journal of Infectious Diseases 140:527–533
   [Google Scholar]
8. Halstead S. B. 1981; The pathogenesis of dengue: molecular epidemiology in infectious disease. American Journal of Epidemiology 114:632–648
   [Google Scholar]
9. Halstead S. B., Porterfield J. S., O’Rourke E. J. 1980; Enhancement of dengue virus infection in monocytes by flavivirus antisera. American Journal of Tropical Medicine and Hygiene 29:638–642
   [Google Scholar]
10. Halstead S. B., Larsen K., Kliks K., Peiris J. S. M., Cardosa J., Porterfield J. S. 1983; Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection enhancing antibodies. American Journal of Tropical Medicine and Hygiene 32:157–163
    [Google Scholar]
11. Halstead S. B., Venkateshan C. N., Gentry M. K., Larsen L. K. 1984; Heterogeneity of infection enhancement of dengue-2 strains by monoclonal antibodies. Journal of Immunology 132:1529–1532
    [Google Scholar]
12. Peiris J. S. M., Porterfield J. S., Roehrig J. T. 1982; Monoclonal antibodies against the flavivirus West Nile. Journal of General Virology 58:283–289
    [Google Scholar]
13. Porterfield J. S. 1982; Immunological enhancement and the pathogenesis of dengue haemorrhagic fever. Journal of Hygiene 89:355–364
    [Google Scholar]
14. Porterfield J. S., Cardosa M. S. 1984; Host range and tissue tropisms: antibody-dependent mechanisms. In Concepts in Viral Pathogenesis pp 177–122 Edited by Notkins A. L., Oldstone M. B. A. New York: Springer-Verlag;
    [Google Scholar]
15. Prabhakar B. S., Nathanson N. 1981; Acute rabies death mediated by antibody. Nature, London 290:590–591
    [Google Scholar]
16. Schlesinger J. S., Brandriss M. W. 1983; 17D yellow fever virus infection of P388D₁ cells mediated by monoclonal antibodies: properties of the macrophage Fc receptor. Journal of General Virology 64:1255–1262
    [Google Scholar]
17. Weiss R. C., Scott F. W. 1981; Antibody mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue haemorrhagic fever. Comparative Immunology, Microbiology and Infectious Disease 4:175–189
    [Google Scholar]